175 related articles for article (PubMed ID: 17430088)
21. A comparative analysis of constitutive promoters located in adeno-associated viral vectors.
Damdindorj L; Karnan S; Ota A; Hossain E; Konishi Y; Hosokawa Y; Konishi H
PLoS One; 2014; 9(8):e106472. PubMed ID: 25170953
[TBL] [Abstract][Full Text] [Related]
22. AAV-mediated gene transfer to mouse lungs.
Halbert CL; Miller AD
Methods Mol Biol; 2004; 246():201-12. PubMed ID: 14970594
[TBL] [Abstract][Full Text] [Related]
23. Enhancing rAAV vector expression in the lung.
Virella-Lowell I; Zusman B; Foust K; Loiler S; Conlon T; Song S; Chesnut KA; Ferkol T; Flotte TR
J Gene Med; 2005 Jul; 7(7):842-50. PubMed ID: 15838934
[TBL] [Abstract][Full Text] [Related]
24. Distinct Expression Patterns of AAV8 Vectors with Broadly Active Promoters from Subretinal Injections of Neonatal Mouse Eyes at Two Different Ages.
Xiong W; Cepko C
Adv Exp Med Biol; 2016; 854():501-7. PubMed ID: 26427452
[TBL] [Abstract][Full Text] [Related]
25. High-efficiency transduction of primary human hematopoietic stem cells and erythroid lineage-restricted expression by optimized AAV6 serotype vectors in vitro and in a murine xenograft model in vivo.
Song L; Li X; Jayandharan GR; Wang Y; Aslanidi GV; Ling C; Zhong L; Gao G; Yoder MC; Ling C; Tan M; Srivastava A
PLoS One; 2013; 8(3):e58757. PubMed ID: 23516552
[TBL] [Abstract][Full Text] [Related]
26. Efficient transduction of human neurons with an adeno-associated virus vector.
Du B; Wu P; Boldt-Houle DM; Terwilliger EF
Gene Ther; 1996 Mar; 3(3):254-61. PubMed ID: 8646557
[TBL] [Abstract][Full Text] [Related]
27. Targeting transgene to the heart and liver with AAV9 by different promoters.
Chen BD; He CH; Chen XC; Pan S; Liu F; Ma X; Li XM; Gai MT; Tao J; Ma YT; Yang YN; Gao XM
Clin Exp Pharmacol Physiol; 2015 Oct; 42(10):1108-17. PubMed ID: 26173818
[TBL] [Abstract][Full Text] [Related]
28. Construction and analysis of compact muscle-specific promoters for AAV vectors.
Wang B; Li J; Fu FH; Chen C; Zhu X; Zhou L; Jiang X; Xiao X
Gene Ther; 2008 Nov; 15(22):1489-99. PubMed ID: 18563184
[TBL] [Abstract][Full Text] [Related]
29. Successful readministration of adeno-associated virus vectors to the mouse lung requires transient immunosuppression during the initial exposure.
Halbert CL; Standaert TA; Wilson CB; Miller AD
J Virol; 1998 Dec; 72(12):9795-805. PubMed ID: 9811715
[TBL] [Abstract][Full Text] [Related]
30. A Single Vector Platform for High-Level Gene Transduction of Central Neurons: Adeno-Associated Virus Vector Equipped with the Tet-Off System.
Sohn J; Takahashi M; Okamoto S; Ishida Y; Furuta T; Hioki H
PLoS One; 2017; 12(1):e0169611. PubMed ID: 28060929
[TBL] [Abstract][Full Text] [Related]
31. JSRV Intragenic Enhancer Element Increases Expression from a Heterologous Promoter and Promotes High Level AAV-mediated Transgene Expression in the Lung and Liver of Mice.
Yu DL; Chow N; Wootton SK
Viruses; 2020 Nov; 12(11):. PubMed ID: 33172105
[TBL] [Abstract][Full Text] [Related]
32. Comparison of retroviral and adeno-associated viral vectors designed to express human clotting factor IX.
Chen L; Perlick H; Morgan RA
Hum Gene Ther; 1997 Jan; 8(2):125-35. PubMed ID: 9017417
[TBL] [Abstract][Full Text] [Related]
33. Adeno-associated virus types 5 and 6 use distinct receptors for cell entry.
Seiler MP; Miller AD; Zabner J; Halbert CL
Hum Gene Ther; 2006 Jan; 17(1):10-9. PubMed ID: 16409121
[TBL] [Abstract][Full Text] [Related]
34. Adeno-associated virus vectors serotyped with AAV8 capsid are more efficient than AAV-1 or -2 serotypes for widespread gene delivery to the neonatal mouse brain.
Broekman ML; Comer LA; Hyman BT; Sena-Esteves M
Neuroscience; 2006; 138(2):501-10. PubMed ID: 16414198
[TBL] [Abstract][Full Text] [Related]
35. Chromosomal latency and expression at map unit 96 of a wild-type plus adeno-associated virus (AAV)/Neo vector and identification of p81, a new AAV transcriptional promoter.
Hermonat PL; Santin AD; De Greve J; De Rijcke M; Bishop BM; Han L; Mane M; Kokorina N
J Hum Virol; 1999; 2(6):359-68. PubMed ID: 10774553
[TBL] [Abstract][Full Text] [Related]
36. Comparison of adeno-associated viral vector serotypes for spinal cord and motor neuron gene delivery.
Snyder BR; Gray SJ; Quach ET; Huang JW; Leung CH; Samulski RJ; Boulis NM; Federici T
Hum Gene Ther; 2011 Sep; 22(9):1129-35. PubMed ID: 21443428
[TBL] [Abstract][Full Text] [Related]
37. Purkinje-cell-preferential transduction by lentiviral vectors with the murine stem cell virus promoter.
Takayama K; Torashima T; Horiuchi H; Hirai H
Neurosci Lett; 2008 Sep; 443(1):7-11. PubMed ID: 18675313
[TBL] [Abstract][Full Text] [Related]
38. Systemic AAV-9 transduction in mice is influenced by animal age but not by the route of administration.
Bostick B; Ghosh A; Yue Y; Long C; Duan D
Gene Ther; 2007 Nov; 14(22):1605-9. PubMed ID: 17898796
[TBL] [Abstract][Full Text] [Related]
39. An improved system for packaging recombinant adeno-associated virus vectors capable of in vivo transduction.
Flotte TR; Barraza-Ortiz X; Solow R; Afione SA; Carter BJ; Guggino WB
Gene Ther; 1995 Jan; 2(1):29-37. PubMed ID: 7712331
[TBL] [Abstract][Full Text] [Related]
40. Self-complementary adeno-associated virus 2 (AAV)-T cell protein tyrosine phosphatase vectors as helper viruses to improve transduction efficiency of conventional single-stranded AAV vectors in vitro and in vivo.
Zhong L; Chen L; Li Y; Qing K; Weigel-Kelley KA; Chan RJ; Yoder MC; Srivastava A
Mol Ther; 2004 Nov; 10(5):950-7. PubMed ID: 15509512
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
